Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs

OBJECTIVE: To investigate whether calprotectin (S100A8/A9 or MRP8/14), an inflammatory complex released by monocytes, could indicate residual subclinical inflammation in rheumatoid arthritis (RA) patients who are in stable remission on disease-modifying anti-rheumatic drugs (DMARDs) and serve as a m...

Descripción completa

Detalles Bibliográficos
Autores principales: de Moel, Emma C., Rech, Jürgen, Mahler, Michael, Roth, Johannes, Vogl, Thomas, Schouffoer, Anne, Goekoop, Robbert J., Huizinga, Tom W. J., Allaart, Cornelia F., Toes, René E. M., Schett, Georg, van der Woude, Diane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894482/
https://www.ncbi.nlm.nih.gov/pubmed/31805992
http://dx.doi.org/10.1186/s13075-019-2064-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894482/
https://www.ncbi.nlm.nih.gov/pubmed/31805992
http://dx.doi.org/10.1186/s13075-019-2064-y

Ejemplares similares